Pricing Log in Create free account
Friday 6 November 2026 Export LNTH’s income statement to Excel — free account

Lantheus Holdings, Inc.

LNTH Healthcare Drug Manufacturers Specialty & Generic

Lantheus Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 0.50% from fiscal 2024.

Revenue
+1.54%
EPS
−17.1%
Free cash flow
+7.71%
Total debt
+0.52%

Quarter to September 2026, against a year earlier

100.54 0.16 −0.16%
Market cap
$6.6B
P/E
24.3×
Fwd P/E
21.3×
Dividend yield
—
F-score
5/9
Altman Z
4.25
Beneish M
−2.23
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Lantheus Holdings, Inc. (LNTH) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Lantheus Holdings, Inc. (LNTH) trades at a P/E ratio of 24.3×. Over the past ten years it has ranged from 0.0× (June 2023) to 202× (March 2023); the current reading is higher than 77% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 20.5× and in line with the Healthcare sector median of 25.2×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 19.3× (2.25%)
FY2024 19.8× 49.93%
FY2023 13.2× (89.32%)
FY2022 124× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 25.3× 71.50%
FY2018 14.8× 131.31%
FY2017 6.4× (38.69%)
FY2016 10.4× —

Quarterly newest first

Period P/E ratio Change
Sep 2026 24.0× (8.77%)
Jun 2026 26.4× 46.26%
Mar 2026 18.0× (6.87%)
Dec 2025 19.3× (7.59%)
43 more quarters

Against its own ten years

Low 0.0× High 202×
Ten-year median 17.4×
Current reading's percentile 70

P/E ratio against peers

Company P/E ratio
HIMS Hims & Hers Health, Inc. compare n/m
AMLX Amylyx Pharmaceuticals, Inc. compare n/m
ALKS Alkermes plc compare n/m
SUPN Indivior Pharmaceuticals Inc. compare 7.6×
LNTH Lantheus Holdings, Inc. 24.3×
LQDA Liquidia Corporation compare 28.5×
AMRX AMNEAL PHARMACEUTICALS, INC. compare 36.9×
RDY Dr. Reddy's Laboratories Ltd compare 44.4×
KNSA Kiniksa Pharmaceuticals International, plc compare 62.1×
Drug Manufacturers Specialty & Generic industry median 20.5×
Healthcare sector median 25.2×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on LNTH